PETALING JAYA: The whistleblower system set up to report Covid-19 vaccination queue jumpers has enabled the Special Committee on Ensuring Access to Covid-19 Vaccine Supply (JKJAV) to fine-tune the distribution of vaccines to more deserving groups, says Khairy Jamaluddin.
The Science, Technology and Innovation Minister said as of Friday (March 5), he had received 200 complaints about queue jumping, although not all provided evidence of their claims.
"One of the complaints also led us to rethink our priorities. For example, we received complaints from a hospital where its emergency room staff was not listed as early recipients of the vaccine and we have corrected this," he said.
Another complaint on March 4 was about vaccines being distributed to people that did not meet the requirements for first phase eligibility.
Investigations later revealed that the area concerned had completed the vaccination of frontliners and had extra doses and had planned to give it to others.
"We cancelled their plans and the appointments of those who were to get vaccinated, and channelled the surplus to other areas that have yet to complete inoculating frontliners," he said.
Khairy said the whistleblower system enabled JKJAV to rectify situations that might have resulted from unclear planning.
He said this in a joint press conference with Health Minister Datuk Seri Adham Baba on the progress of the National Covid-19 Immunisation programme on Monday (March 8).
On Feb 28, Khairy said whistleblowers could email him anonymously at firstname.lastname@example.org to report vaccine queue jumpers.
Khairy also said Malaysia would be receiving the next delivery of the Pfizer-BioNTech vaccine on Thursday (March 11).
He said 200,000 doses of the Sinovac vaccine would be arriving in Malaysia in two batches, with the first on March 15 and the other on March 19.
Khairy also said the Health Ministry was finalising a deal with Pfizer to provide a total of 32 million doses of the company's Comirnaty vaccine, equivalent to covering 50% of the country's population.
"We will be signing that deal this week and we can expect the arrival of the 32 million doses of the Pfizer-BioNTech vaccine this year," he said.
He said the government is also mulling whether to accept Pfizer's offer to provide an additional 20% of the vaccine to Malaysia.
Khairy said the government was also hastening negotiations with CanSino to include a one-dose Covid-19 vaccine into its portfolio.
He said the CanSino was a better option than the Johnson & Johnson single-dose vaccine, which could only arrive in Malaysia by the fourth quarter of 2021.
Khairy said JKJAV is also considering the Novovax vaccine from the United States, which had a 89.3% efficacy in clinical trials in the United Kingdom.
So far, 3,832,976 people have registered for the vaccine in Malaysia with a majority of them doing so through the MySejahtera app.
Khairy also said the 571,802 frontliners would be completely vaccinated by the end of March.
"All of them would at least have received their first shot by then," he said.